Gabelli Healthcare & Wellness (GRX) vs Stellus Capital Investment (SCM)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Gabelli Healthcare & Wellness (GRX) has outperformed Stellus Capital Investment (SCM) over the past year, gaining 6.3% versus a loss of 48.4%. Over five years, GRX leads with a -23.9% price change compared with -55.6% for SCM. Stellus Capital Investment is the larger company by market cap ($172.5 million vs $144.9 million), about 1.2 times the size.
On valuation, Stellus Capital Investment trades at a lower trailing P/E (10.7x vs 17.5x for Gabelli Healthcare & Wellness). Stellus Capital Investment pays a dividend yielding 21.72%, while Gabelli Healthcare & Wellness does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | GRX | SCM |
|---|---|---|
| Share price | $9.96 | $6.12 |
| Market cap | $144.87M | $172.46M |
| 1-day change | -1.09% | -2.55% |
| YTD return | +3.43% | -51.74% |
| 1-year return | +6.30% | -48.35% |
| 5-year return | -23.91% | -55.59% |
| P/E ratio (TTM) | 17.47 | 10.74 |
| Forward P/E | — | 6.00 |
| EPS (TTM) | $0.57 | $0.57 |
| Dividend yield | 8.03% | 21.72% |
| Annual dividend | $0.00 | $1.33 |
| Net income (latest FY) | — | $27.05M |
| 52-week high | $10.76 | $13.55 |
| 52-week low | $8.80 | $6.12 |
| Distance from 52-week high | -7.43% | -54.83% |
| Analyst consensus | — | hold |
| Avg. price target upside | — | +59.31% |
| Average volume | 19.40K | 160.13K |
| Shares outstanding | 14.54M | 28.18M |
| Sector | Finance | Finance |
| Industry | Finance/Investors Services | Finance/Investors Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- GRX has outperformed SCM by 54.7 percentage points over the past year.
- Gabelli Healthcare & Wellness trades at a higher earnings multiple (17.5x vs 10.7x trailing P/E).
- Stellus Capital Investment offers a meaningfully higher dividend yield (21.72% vs 8.03%).
About Gabelli Healthcare & Wellness
GRX stock →The Gabelli Healthcare & Wellness Trust is a closed-ended equity mutual fund launched by GAMCO Investors, Inc. The fund is managed by Gabelli Funds, LLC.
Finance · Finance/Investors Services
About Stellus Capital Investment
SCM stock →Stellus Capital Investment Corporation is a business development company specializing in investments in private middle-market companies. It invests through first lien, second lien, unitranche, and mezzanine debt financing, often with a corresponding equity investment.
Finance · Finance/Investors Services
GRX vs SCM FAQ
Which is bigger, Gabelli Healthcare & Wellness or Stellus Capital Investment?
Stellus Capital Investment (SCM) is larger, with a market capitalization of $172.46M compared with $144.87M for Gabelli Healthcare & Wellness (GRX).
Which stock has performed better over the past year, GRX or SCM?
GRX returned +6.30% over the past 12 months, compared with -48.35% for SCM (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, GRX or SCM?
SCM has the lower trailing P/E at 10.7, versus 17.5 for GRX. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Gabelli Healthcare & Wellness or Stellus Capital Investment?
Stellus Capital Investment has the higher yield at 21.72%, compared with 8.03% for Gabelli Healthcare & Wellness.
Are Gabelli Healthcare & Wellness and Stellus Capital Investment in the same industry?
Yes. Both are classified in the Finance/Investors Services industry within the Finance sector.